Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-17 and airway remodelling.

Anders Lindén1

  • 1Department of Medicine, Cooperative Research Centre for Chronic Inflammatory Diseases, The University of Melbourne, Parkville, Vic., Australia. anders.linden@lungall.gu.se

Pulmonary Pharmacology & Therapeutics
|November 16, 2005
PubMed
Summary

Interleukin-17A (IL-17A) shows potential in innate immunity and allergic airway diseases. Further research is needed to confirm its causative role and therapeutic potential in airway remodelling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of airway mucin 5AC and 5B expression in preterm-born adults and asthma.

ERJ open research·2026
Same author

Increased levels of α2-3- and α2-6-linked sialic acids during airway inflammation govern influenza A binding to peripheral airway mucins in a subtype-dependent manner.

Frontiers in immunology·2026
Same author

No association between troponin and COPD without cardiovascular influence: findings from a population-based cohort (SCAPIS).

Thorax·2026
Same author

Corrigendum to "Plasma proteins associated with cardiovascular disease in relation to lung function in SCAPIS" [Respir. Med. 249 (2025) 108463-108463].

Respiratory medicine·2026
Same author

Plasma proteins associated with cardiovascular disease in relation to lung function in SCAPIS.

Respiratory medicine·2025
Same author

Occupational exposures to inorganic dust are associated with emphysema: the SCAPIS cohort.

Occupational and environmental medicine·2025

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Allergy Research

Background:

  • Interleukin-17A (IL-17A) is recognized for its role in innate immunity, particularly in neutrophil mobilization.
  • While associated with airway diseases, IL-17A's direct causative role in pathogenesis remains unproven.
  • Existing evidence suggests IL-17A's involvement in allergen-induced airway hyperresponsiveness in mice.

Purpose of the Study:

  • To investigate the pathogenic role of IL-17A in airway diseases.
  • To determine if IL-17A contributes to airway remodelling in vivo.
  • To evaluate IL-17A as a potential therapeutic target for allergic airway disease.

Main Methods:

  • Review of existing literature on IL-17A's function in innate immunity and airway diseases.
  • Analysis of studies demonstrating IL-17A's effects on airway cells and in mouse models.
  • Identification of knowledge gaps requiring further in vivo investigation.

Main Results:

  • IL-17A orchestrates sustained neutrophilic mobilization, reinforcing innate immunity.
  • IL-17A stimulates airway cells to release cytokines implicated in airway remodelling.
  • Evidence from mouse models suggests IL-17A contributes to allergen-induced airway hyperresponsiveness.

Conclusions:

  • IL-17A's precise role in the pathogenesis of airway diseases requires further elucidation.
  • Investigating the in vivo contribution of IL-17A-stimulated cytokine release to airway remodelling is crucial.
  • IL-17A presents a potential pharmacotherapeutic target for allergic airway diseases if its causative role is confirmed.

Related Experiment Videos